VIEWPOINT BIOPHARMA Trademark

Trademark Overview

On Friday, July 10, 2026, a trademark application was filed for VIEWPOINT BIOPHARMA with the United States Patent and Trademark Office. The USPTO has given the VIEWPOINT BIOPHARMA trademark a serial number of 99933476. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 10, 2026. This trademark is owned by Perspective Therapeutics, Inc.. The VIEWPOINT BIOPHARMA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

nuclear medicine; contract research services in the field of radiopharmaceutical drug discovery and development; preclinical research and development services relating to radiolabeled compounds for cancer therapy and diagnosis; scientific consultation services in the field of targeted radionuclide therapy; laboratory research services in the field of radiochemistry and radiopharmaceutical development; drug discovery research services in the field of oncology radiopharmaceuticals; scientific and technological services relating to the development of radiolabeled targeted alpha therapy compounds; research and development services relating to theranostic radiopharmaceutical platforms

Radiopharmaceutical preparations; Radiopharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for the diagnosis of cancer; targeted alpha therapy radiopharmaceutical preparations for the treatment of cancer; radioligand therapy preparations comprising radiolabeled targeting compounds for oncological use; radiopharmaceutical diagnostic agents for use in nuclear medicine imaging; radiopharmaceutical preparations for the treatment of cancers; radiolabeled peptide conjugates for use in cancer therapy; radiopharmaceutical preparations for theranostic applications in oncology

Radiopharmaceutical chemical compounds; radiolabeled chemical compounds comprising alpha-emitting radionuclides; bifunctional chelating agents for conjugating radionuclides to targeting molecules; chemical precursors for use in the manufacture of radiopharmaceuticals; chelating compounds for radiolabeling of peptides and small molecules; radioactive isotope-labeled chemical intermediates for pharmaceutical research and manufacturing
viewpoint biopharma

General Information

Serial Number99933476
Word MarkVIEWPOINT BIOPHARMA
Filing DateFriday, July 10, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, July 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesnuclear medicine; contract research services in the field of radiopharmaceutical drug discovery and development; preclinical research and development services relating to radiolabeled compounds for cancer therapy and diagnosis; scientific consultation services in the field of targeted radionuclide therapy; laboratory research services in the field of radiochemistry and radiopharmaceutical development; drug discovery research services in the field of oncology radiopharmaceuticals; scientific and technological services relating to the development of radiolabeled targeted alpha therapy compounds; research and development services relating to theranostic radiopharmaceutical platforms
Pseudo MarkVIEWPOINT BIOLOGICAL PHARMACEUTICAL
Goods and ServicesRadiopharmaceutical preparations; Radiopharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for the diagnosis of cancer; targeted alpha therapy radiopharmaceutical preparations for the treatment of cancer; radioligand therapy preparations comprising radiolabeled targeting compounds for oncological use; radiopharmaceutical diagnostic agents for use in nuclear medicine imaging; radiopharmaceutical preparations for the treatment of cancers; radiolabeled peptide conjugates for use in cancer therapy; radiopharmaceutical preparations for theranostic applications in oncology
Pseudo MarkVIEWPOINT BIOPHARMACEUTICAL
Pseudo MarkVIEWPOINT BIO PHARMA
Goods and ServicesRadiopharmaceutical chemical compounds; radiolabeled chemical compounds comprising alpha-emitting radionuclides; bifunctional chelating agents for conjugating radionuclides to targeting molecules; chemical precursors for use in the manufacture of radiopharmaceuticals; chelating compounds for radiolabeling of peptides and small molecules; radioactive isotope-labeled chemical intermediates for pharmaceutical research and manufacturing

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, July 10, 2026
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 10, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 10, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePerspective Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98121
US

Trademark Events

Event DateEvent Description
Friday, July 10, 2026NEW APPLICATION ENTERED
Friday, July 10, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

biopharma viewpoint radiopharmaceutical services preparations compounds research therapy development cancer radiolabeled field